Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Repurposing Tumor Cells: A Paradigm Shift in Cell-Based Therapies for Cancer.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Same author

Advancing Lung Cancer Treatment: mRNA Therapeutics and Delivery Strategies.

Nano letters·2025

Same author

Systemic reprogramming of tumour immunity via IL-10-mRNA nanoparticles.

Nature nanotechnology·2025

Same author

Oral delivery of liquid mRNA therapeutics by an engineered capsule for treatment of preclinical intestinal disease.

Science translational medicine·2025

Same author

mRNA-based enzyme replacement for propionic acidaemia.

Nature reviews. Endocrinology·2025

Same author

Author Correction: Immune phenotyping of diverse syngeneic murine brain tumors identifies immunologically distinct types.

Nature communications·2025

Same journal

Publisher Correction: Ultralow-voltage electrochemical organic light-emitting transistors with pinned and wide lateral recombination.

Nature materials·2026

Same journal

High-Chern-number orbital magnetism in twisted rhombohedral graphene.

Nature materials·2026

Same journal

Programming local confinements in crystalline frameworks through reticular chemistry.

Nature materials·2026

Same journal

Single-crystal-like polymer semiconductors via self-templated gradient assembly for ultrahigh charge carrier mobility.

Nature materials·2026

Same journal

Fractional quantum anomalous Hall effect in moiré fractional Chern insulators.

Nature materials·2026

Same journal

Excitons in van der Waals magnetic materials.

Nature materials·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Jul 9, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Taming CAR T cell therapy toxicity

Chuang Liu^1,2, Khalid Shah^3,4,5

¹Center for Stem Cell and Translational Immunotherapy, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.

Nature Materials

|November 30, 2023

Summary

No abstract available in PubMed .

More Related Videos

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022

Related Experiment Videos

Last Updated: Jul 9, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography

Published on: February 17, 2022